Porphyromonas Denticanis-Gulae-Salivosa Bacterin*(Porphyromonas Vaccine)

Did you know that more than 85% of dogs older than 3 have a painful and damaging disease called Periodontitis!  
Periodontal disease is caused by a bacteria called Porphyromonas, which lives in the palque build-up on your pet's teeth. This bacterium is not professionally removed will damage the tooth's structural support such as the tooth and the gum.  

Now in addition to your dental program already, we have a new vaccine called Porphyromonas vaccine, which will help kill the bacteria living in your dogs mouth.  This vaccine aids in the prevention of periodontal disease, it will not prevent periodontal disease alone.  Daily brushing and professional dental prophylaxis are needed to maintain the best oral health possible. 

 Product Description

The Porphyromonas Denticanis-Gulae-Salivosa Bacterin is approved for the vaccination of healthy dogs as an aid in preventing periodontitis, as demonstrated by a reduction in bone changes (osteolysis/osteosclerosis).

• Porphyromonas Denticanis-Gulae-Salivosa Bacterin is the first and only vaccine to aid in the prevention of canine periodontitis which affects 85% of dogs over 3 years of age.¹
• This product is an important new adjunct to professional dental cleaning, periodontal therapy and owner-administrated dental care routines.
• The Porphyromonas Vaccine is part of a complete canine wellness program that encourages annual visits.
• Safety of the vaccine was evaluated in laboratory studies and a field safety study.

• Inactivated P. denticanis, P. gulae and P. salivosa bacterin (liquid form)
• Adjuvant to enhance immune response
• Primary vaccination—two doses, three week apart
• Twenty-five 1 mL doses per carton
• Adminster 1 mL subcutaneously

• General Directions: Vaccination of healthy dogs is recommended. Shake well. Aspetically administer 1 mL subcutaneously.
• Primary Vaccination: Healthy dogs should receive 2 doses administered 3 weeks apart.
• Revaccination: Duration of immunity for this product has not been determined; six and twelve month intervals are being evaluated.